James B Breitmeyer
CIK 0001244823
Summary
- Name
- James B Breitmeyer
- CIK
- 0001244823
- Insider filer
- Yes
- Known positions
- 5
Current roles
| Company | Ticker | Role | Title | Tenure |
|---|---|---|---|---|
| Vaxart, Inc. | VXRT | director | — | 2026-05-01 |
| Company | Ticker | Role | Title | Tenure |
|---|---|---|---|---|
| Vaxart, Inc. | VXRT | director | — | 2026-05-01 |
| Oncternal Therapeutics, Inc. | ONCT | officer | CEO | 2019-06-11 → 2024-02-15 |
| OTONOMY, INC. | OTIC | director | — | 2018-06-20 → 2022-06-23 |
| ZOGENIX, INC. | ZGNX | director | — | 2014-03-26 → 2022-03-09 |
| CADENCE PHARMACEUTICALS INC | CADX | officer | CMO | 2006-10-24 → 2012-03-16 |
| Date | Issuer | Form | Code | A/D | Shares | Price |
|---|---|---|---|---|---|---|
| 2026-07-16 | Vaxart, Inc. VXRT | 4 | A | A | 8.3K | $0.00 |
| 2026-07-16 | Vaxart, Inc. VXRT | 4 | A | A | 16.6K | $0.00 |
| 2026-04-23 | Vaxart, Inc. VXRT | 4 | A | A | 78.8K | $0.00 |
| 2026-04-23 | Vaxart, Inc. VXRT | 4 | A | A | 157.4K | $0.00 |
| 2024-02-14 | Oncternal Therapeutics, Inc. ONCT | 4 | A | A | 28.4K | $0.00 |
| 2024-02-14 | Oncternal Therapeutics, Inc. ONCT | 4 | A | A | 6.2K | $0.00 |
| 2024-01-03 | Oncternal Therapeutics, Inc. ONCT | 4 | F | D | 4.5K | $0.50 |
| 2024-01-03 | Oncternal Therapeutics, Inc. ONCT | 4 | F | D | 51.0K | $0.50 |
| 2023-10-02 | Oncternal Therapeutics, Inc. ONCT | 4 | D | D | 22.0K | — |
| 2023-10-02 | Oncternal Therapeutics, Inc. ONCT | 4 | D | D | 7.0K | — |
| 2023-10-02 | Oncternal Therapeutics, Inc. ONCT | 4 | D | D | 2.0K | — |
| 2023-10-02 | Oncternal Therapeutics, Inc. ONCT | 4 | D | D | 165.0K | — |
| 2023-10-02 | Oncternal Therapeutics, Inc. ONCT | 4 | D | D | 12.5K | — |
| 2023-10-02 | Oncternal Therapeutics, Inc. ONCT | 4 | D | D | 65.0K | — |
| 2023-10-02 | Oncternal Therapeutics, Inc. ONCT | 4 | A | A | 22.0K | — |
| 2023-10-02 | Oncternal Therapeutics, Inc. ONCT | 4 | A | A | 7.0K | — |
| 2023-10-02 | Oncternal Therapeutics, Inc. ONCT | 4 | A | A | 2.0K | — |
| 2023-10-02 | Oncternal Therapeutics, Inc. ONCT | 4 | A | A | 165.0K | — |
| 2023-10-02 | Oncternal Therapeutics, Inc. ONCT | 4 | A | A | 12.5K | — |
| 2023-10-02 | Oncternal Therapeutics, Inc. ONCT | 4 | A | A | 65.0K | — |
| 2023-10-02 | Oncternal Therapeutics, Inc. ONCT | 4 | D | D | 100.0K | — |
| 2023-10-02 | Oncternal Therapeutics, Inc. ONCT | 4 | D | D | 66.9K | — |
| 2023-10-02 | Oncternal Therapeutics, Inc. ONCT | 4 | D | D | 750.0K | — |
| 2023-10-02 | Oncternal Therapeutics, Inc. ONCT | 4 | D | D | 637.0K | — |
| 2023-10-02 | Oncternal Therapeutics, Inc. ONCT | 4 | D | D | 123.8K | — |
| 2023-10-02 | Oncternal Therapeutics, Inc. ONCT | 4 | D | D | 650.0K | — |
| 2023-10-02 | Oncternal Therapeutics, Inc. ONCT | 4 | A | A | 100.0K | — |
| 2023-10-02 | Oncternal Therapeutics, Inc. ONCT | 4 | A | A | 66.9K | — |
| 2023-10-02 | Oncternal Therapeutics, Inc. ONCT | 4 | A | A | 750.0K | — |
| 2023-10-02 | Oncternal Therapeutics, Inc. ONCT | 4 | A | A | 637.0K | — |
| 2023-10-02 | Oncternal Therapeutics, Inc. ONCT | 4 | A | A | 123.8K | — |
| 2023-10-02 | Oncternal Therapeutics, Inc. ONCT | 4 | A | A | 650.0K | — |
| 2023-07-03 | Oncternal Therapeutics, Inc. ONCT | 4 | F | D | 48.0K | $0.36 |
| 2023-07-03 | Oncternal Therapeutics, Inc. ONCT | 4 | F | D | 4.0K | $0.36 |
| 2023-04-14 | Oncternal Therapeutics, Inc. ONCT | 4 | P | A | 2.3K | $0.29 |
| 2023-04-14 | Oncternal Therapeutics, Inc. ONCT | 4 | P | A | 47.8K | $0.30 |
| 2023-04-13 | Oncternal Therapeutics, Inc. ONCT | 4 | P | A | 100.0K | $0.29 |
| 2023-02-21 | Oncternal Therapeutics, Inc. ONCT | 4 | A | A | 42.2K | $0.00 |
| 2023-02-21 | Oncternal Therapeutics, Inc. ONCT | 4 | A | A | 65.0K | $0.00 |
| 2023-02-21 | Oncternal Therapeutics, Inc. ONCT | 4 | A | A | 650.0K | $0.00 |
| 2023-01-03 | Oncternal Therapeutics, Inc. ONCT | 4 | F | D | 1.3K | $1.02 |
| 2023-01-03 | Oncternal Therapeutics, Inc. ONCT | 4 | F | D | 27.8K | $1.02 |
| 2022-07-28 | Oncternal Therapeutics, Inc. ONCT | 4 | A | A | 18.8K | $0.00 |
| 2022-07-28 | Oncternal Therapeutics, Inc. ONCT | 4 | A | A | 185.6K | $0.00 |
| 2022-07-28 | Oncternal Therapeutics, Inc. ONCT | 4 | A | A | 123.8K | $0.00 |
| 2022-07-28 | Oncternal Therapeutics, Inc. ONCT | 4 | A | A | 12.5K | $0.00 |
| 2022-06-21 | OTONOMY, INC. OTIC | 4 | A | A | 27.5K | $0.00 |
| 2022-03-07 | ZOGENIX, INC. ZGNX | 4 | U | D | 1.3K | — |
| 2022-03-07 | ZOGENIX, INC. ZGNX | 4 | D | D | 9.4K | — |
| 2022-03-07 | ZOGENIX, INC. ZGNX | 4 | D | D | 6.3K | — |
Frequently asked questions
What is James B Breitmeyer's CIK number?
James B Breitmeyer's SEC CIK number is 0001244823 (1244823). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find James B Breitmeyer's SEC filings?
All of James B Breitmeyer's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.